Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

The Magneto 150 is a high-powered 150W holmium laser that offers similar pulse-modulation benefits of MOSES 2.0, which facilitates effective dissection and enucleation of the tissue plane while also offering a new first-of-its kind proprietary Magneto setting which allows for very low peak power of 500W and longer pulse duration which allows for better hemostasis.

Inclusion Criteria:

• Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
• Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)

Exclusion Criteria:

• Patients who lack decisional capacity
• Patients unable to read/speak English
• Patients who are on a blood thinner (anticoagulation medication)
• Patients who do not have internet access to complete postoperative surveys